Funding news
CereVasc logo

CereVasc Raises $85.

Recently funded · $85.0M Series cHospitals and Health CareUSView source

Get the full CereVasc company profile

Access contacts, investors, buying signals & more

Open in Dashboard

CereVasc, Inc., which is developing the eShunt System for the treatment of communicating hydrocephalus, has secured $85.0M in Series C funding. This substantial capital infusion will advance the company's work on its novel device, designed to address one of the most common neurological conditions affecting both children and adults.

The Series C round underscores continued momentum for CereVasc as it progresses with the eShunt System. The device aims to provide a new therapeutic option for patients with communicating hydrocephalus, a condition impacting a broad demographic.

From the source

FinSMEs · Jun 4, 2026

CereVasc, Inc., a Boston, MA-based clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, raised $85M in Series C funding https://lnkd.in/e3TVQQEF / Access the FinSMEs Intelligence Hub using the code DISCOUNTFOUNDER for 30% off! 👉 https://lnkd.in/dCSjx_V3

Other United States companies recently funded

View all

Biggest recent Healthcare rounds

Largest funding rounds in Healthcare on Signalbase right now.

#CompanyAmount
1
Kismet logo

Kismet

Australia

$42.0B
2
Johnson & Johnson logo

Johnson & Johnson

United States

$7.0B
3
Inari Medical logo

Inari Medical

United States

$4.9B
4
MultiPlan logo

MultiPlan

United States

$4.5B
5
Edwards Lifesciences logo

Edwards Lifesciences

United States

$4.2B

Other recent Series c rounds

Companies that recently closed a Series c round.

#CompanyAmount
1
Highland Electric Fleets logo

Highland Electric Fleets

United States

$75.0M
2
Oxford Quantum Circuits (OQC) logo

Oxford Quantum Circuits (OQC)

United Kingdom

$349.9M
3
The Ryl Company™ logo

The Ryl Company™

United States

$20.0M
4
Leverage Edu logo

Leverage Edu

United Kingdom

$20.0M
5
IndustrialX logo

IndustrialX

$12.3M